\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\	on\\ his\\ trunk\\,\\ buttocks\\,\\ and\\ posterior\\ surfaces\\ of\\ upper\\ and\\ lower\\ extremities\\ there\\ were\\ 1\\-4\\ mm\\ soft\\,\\ yellow\\ papules\\ on\\ an\\ erythematous\\ base\\.\\ there\\ were\\ no\\ plaque\\-type\\ lesions\\ present\\ over\\ the\\ elbows\\,\\ knees\\ or\\ fingers\\.\\ abdomen\\ was\\ soft\\ and\\ non\\ tender\\.\\ the\\ corneas\\ were\\ clear\\.\\ laboratory\\:\\	fasting\\ lipid\\ profile\\ was\\ significant\\ for\\ triglycerides\\ 5582\\,\\ total\\ cholesterol\\ 1025\\ and\\ a\\ milky\\ white\\ uppermost\\ layer\\ was\\ noted\\ in\\ the\\ blood\\ collection\\ tube\\.\\ clinical\\ course\\:\\ after\\ a\\ referral\\ to\\ internal\\ medicine\\,\\ the\\ patient\\ was\\ started\\ on\\ gemfibrozil\\.\\ over\\ the\\ following\\ 6\\ weeks\\,\\ his\\	skin\\ lesions\\ resolved\\ and\\ his\\ triglycerides\\ dropped\\ to\\ under\\ 500\\.\ \(0\)\
\-\ after\\ a\\ referral\\ to\\ internal\\ medicine\\,\\ the\\ patient\\ was\ \(0\)\
\-\ started\\ on\\ gemfibrozil\\.\\ over\\ the\\ following\\ 6\\ weeks\\,\\ his\ \(0\)\
\-\ skin\\ lesions\\ resolved\\ and\\ his\\ triglycerides\\ dropped\\ to\ \(2\)\
\-\ under\\ 500\\.\ \(2\)\
\-\ eruptive\\ xanthoma\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\ \\#9\\)\\ mitchell\\ stashower\\,\\ lt\\ mc\\ usnr\\)\ \(0\)\
\-\ patient\\ presented\\ with\\ a\\ 1\\ week\\ history\\	of\\ asymptomatic\\ yellowish\\ lesions\\ that\\ appeared\\ rapidly\\ on\\ his\\ trunk\\ and\\ spread\\ to\\ his\\ extremities\\.\\ his\\ past\\ medical\\ history\\ was\\ notable\\ for\\ pancreatitis\\ 5\\ years\\ ago\\,\\ atherosclerotic\\ peripheral\\ vascular\\ disease\\ and\\ depression\\.\\ patient\\'s\\ brother\\ had\\ a\\ history\\ of\\ pancreatitis\\ and\\ hyperlipidemia\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ triglycerides\\:\\ 0\\.10428251534187012\ \(0\)\
\-\ his\\:\\ 0\\.08875275775304259\ \(0\)\
\-\ 500\\.\\:\\ 0\\.07941908490059908\ \(0\)\
\-\ gemfibrozil\\:\\ 0\\.07317451570636534\ \(0\)\
\-\ dropped\\:\\ 0\\.05703253850611259\ \(0\)\
\-\ trunk\\:\\ 0\\.04848226323857074\ \(0\)\
\-\ referral\\:\\ 0\\.043650689283012405\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.042237694044337\ \(0\)\
\-\ lesions\\:\\ 0\\.04121730642061167\ \(0\)\
\-\ plaque\\-type\\:\\ 0\\.03970954245029954\ \(0\)\
\-\ corneas\\:\\ 0\\.03970954245029954\ \(0\)\
\-\ 5582\\:\\ 0\\.03970954245029954\ \(0\)\
\-\ 1025\\:\\ 0\\.03970954245029954\ \(0\)\
\-\ milky\\:\\ 0\\.03970954245029954\ \(0\)\
\-\ uppermost\\:\\ 0\\.03970954245029954\ \(0\)\
\-\ mitchell\\:\\ 0\\.03970954245029954\ \(0\)\
\-\ stashower\\:\\ 0\\.03970954245029954\ \(0\)\
\-\ resolved\\:\\ 0\\.037321527833374696\ \(0\)\
\-\ medicine\\:\\ 0\\.03651661701953822\ \(0\)\
\-\ eruptive\\:\\ 0\\.03476083844729004\ \(0\)\
\-\ started\\:\\ 0\\.03433848754973909\ \(0\)\
\-\ under\\:\\ 0\\.03364066719803635\ \(0\)\
\-\ 1\\-4\\:\\ 0\\.0334649732560658\ \(0\)\
\-\ yellowish\\:\\ 0\\.0334649732560658\ \(0\)\
\-\ xanthoma\\:\\ 0\\.03163855385017317\ \(0\)\
\-\ fasting\\:\\ 0\\.03094418141851885\ \(0\)\
\-\ usnr\\:\\ 0\\.03094418141851885\ \(0\)\
\-\ extremities\\:\\ 0\\.030195374945413408\ \(0\)\
\-\ elbows\\:\\ 0\\.029812134444280533\ \(0\)\
\-\ skin\\:\\ 0\\.029568729146297098\ \(0\)\
\-\ over\\:\\ 0\\.029400575542431927\ \(0\)\
\-\ brother\\:\\ 0\\.02782189682140198\ \(0\)\
\-\ was\\:\\ 0\\.026710203303072617\ \(0\)\
\-\ were\\:\\ 0\\.026220085630944884\ \(0\)\
\-\ buttocks\\:\\ 0\\.02621525292978607\ \(0\)\
\-\ lipid\\:\\ 0\\.02621525292978607\ \(0\)\
\-\ lt\\:\\ 0\\.02621525292978607\ \(0\)\
\-\ internal\\:\\ 0\\.025809692534943886\ \(0\)\
\-\ surfaces\\:\\ 0\\.02503343191867124\ \(0\)\
\-\ papules\\:\\ 0\\.02503343191867124\ \(0\)\
\-\ profile\\:\\ 0\\.02503343191867124\ \(0\)\
\-\ yellow\\:\\ 0\\.024863430441271032\ \(0\)\
\-\ cholesterol\\:\\ 0\\.024388833523893434\ \(0\)\
\-\ layer\\:\\ 0\\.024388833523893434\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.023825035582659176\ \(0\)\
\-\ fingers\\:\\ 0\\.023092968332669196\ \(0\)\
\-\ atherosclerotic\\:\\ 0\\.023092968332669196\ \(0\)\
\-\ 6\\:\\ 0\\.02299207352589977\ \(0\)\
\-\ mc\\:\\ 0\\.022562414118000806\ \(0\)\
\-\ depression\\:\\ 0\\.022463410033681998\ \(0\)\
\-\ erythematous\\:\\ 0\\.022366535235389368\ \(0\)\
\-\ knees\\:\\ 0\\.022366535235389368\ \(0\)\
\-\ following\\:\\ 0\\.021849349161271608\ \(0\)\
\-\ weeks\\:\\ 0\\.021849349161271608\ \(0\)\
\-\ 1997\\:\\ 0\\.021577327627168238\ \(0\)\
\-\ seminar\\:\\ 0\\.021419258619009365\ \(0\)\
\-\ rapidly\\:\\ 0\\.021342256666940444\ \(0\)\
\-\ notable\\:\\ 0\\.02126654892677657\ \(0\)\
\-\ uniformed\\:\\ 0\\.02119209261168102\ \(0\)\
\-\ appeared\\:\\ 0\\.020975834867598315\ \(0\)\
\-\ services\\:\\ 0\\.020769485606196094\ \(0\)\
\-\ dermatology\\:\\ 0\\.020769485606196094\ \(0\)\
\-\ soft\\:\\ 0\\.018747087963905857\ \(0\)\
\-\ spread\\:\\ 0\\.01861886124703729\ \(0\)\
\-\ total\\:\\ 0\\.016575315256379442\ \(0\)\
\-\ on\\:\\ 0\\.016303851629851984\ \(0\)\
\-\ collection\\:\\ 0\\.016292889156309335\ \(0\)\
\-\ tube\\:\\ 0\\.016218840839448256\ \(0\)\
\-\ history\\:\\ 0\\.015948845104149775\ \(0\)\
\-\ after\\:\\ 0\\.01592793876224507\ \(0\)\
\-\ non\\:\\ 0\\.015911327455984278\ \(0\)\
\-\ 9\\:\\ 0\\.015911327455984278\ \(0\)\
\-\ tender\\:\\ 0\\.015623472492112746\ \(0\)\
\-\ patient\\:\\ 0\\.015434088845340324\ \(0\)\
\-\ \\:\\:\\ 0\\.015273983999873854\ \(0\)\
\-\ \\#\\:\\ 0\\.015097687472706704\ \(0\)\
\-\ base\\:\\ 0\\.015078640913654805\ \(0\)\
\-\ \\,\\:\\ 0\\.014632976514447968\ \(0\)\
\-\ course\\:\\ 0\\.014524916411962348\ \(0\)\
\-\ ago\\:\\ 0\\.014327607300888508\ \(0\)\
\-\ clear\\:\\ 0\\.014232101861020925\ \(0\)\
\-\ laboratory\\:\\ 0\\.014185097909252549\ \(0\)\
\-\ mm\\:\\ 0\\.01415403223781534\ \(0\)\
\-\ peripheral\\:\\ 0\\.013927627576640168\ \(0\)\
\-\ week\\:\\ 0\\.013072141524001027\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.013011677468450843\ \(0\)\
\-\ white\\:\\ 0\\.012766235192396476\ \(0\)\
\-\ vascular\\:\\ 0\\.012620735441097732\ \(0\)\
\-\ past\\:\\ 0\\.012230628252010965\ \(0\)\
\-\ clinical\\:\\ 0\\.011843737838135153\ \(0\)\
\-\ medical\\:\\ 0\\.011843737838135153\ \(0\)\
\-\ there\\:\\ 0\\.011456896905089988\ \(0\)\
\-\ abdomen\\:\\ 0\\.01140263181484548\ \(0\)\
\-\ years\\:\\ 0\\.011302897013596767\ \(0\)\
\-\ 5\\:\\ 0\\.01126198388488362\ \(0\)\
\-\ blood\\:\\ 0\\.010506356182474322\ \(0\)\
\-\ presented\\:\\ 0\\.010492601959560402\ \(0\)\
\-\ significant\\:\\ 0\\.01035066284258659\ \(0\)\
\-\ to\\:\\ 0\\.009618651091058248\ \(0\)\
\-\ physical\\:\\ 0\\.009443717430546119\ \(0\)\
\-\ upper\\:\\ 0\\.009288650925084317\ \(0\)\
\-\ 1\\:\\ 0\\.009159127783602283\ \(0\)\
\-\ noted\\:\\ 0\\.009123518866903576\ \(0\)\
\-\ a\\:\\ 0\\.008932427968887416\ \(0\)\
\-\ posterior\\:\\ 0\\.008872245714875894\ \(0\)\
\-\ present\\:\\ 0\\.008693733125818382\ \(0\)\
\-\ lower\\:\\ 0\\.008657036348485867\ \(0\)\
\-\ \\'s\\:\\ 0\\.008486696479130834\ \(0\)\
\-\ exam\\:\\ 0\\.008456008738511434\ \(0\)\
\-\ case\\:\\ 0\\.00842119113904176\ \(0\)\
\-\ had\\:\\ 0\\.008305629816399587\ \(0\)\
\-\ and\\:\\ 0\\.007297662394549397\ \(0\)\
\-\ that\\:\\ 0\\.00664856184035506\ \(0\)\
\-\ for\\:\\ 0\\.0065685418796641\ \(0\)\
\-\ \\)\\:\\ 0\\.006428267496516262\ \(0\)\
\-\ disease\\:\\ 0\\.006291610546016685\ \(0\)\
\-\ an\\:\\ 0\\.00532281470398527\ \(0\)\
\-\ or\\:\\ 0\\.004511363734070755\ \(0\)\
\-\ the\\:\\ 0\\.004359211679844056\ \(0\)\
\-\ no\\:\\ 0\\.0038758745527198287\ \(0\)\
\-\ \\(\\:\\ 0\\.0032538816497471195\ \(0\)\
\-\ in\\:\\ 0\\.0018981857213524996\ \(0\)\
\-\ \\.\\:\\ 0\\.0015990782025831654\ \(0\)\
\-\ of\\:\\ 0\\.0015743756864593033\ \(0\)\
\-\ with\\:\\ 0\\.0005270458382427466\ \(0\)\
